ConductScience.org, home

Paper3293160

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

Berman JD. Rev Infect Dis, 1988. Cited by 329 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Papers, record 3293160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3293160

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.
PubMed
Journal
Rev Infect Dis
PubMed
Year
1988
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
329
iCite
Relative citation ratio, by iCite
14
iCite
Revised in PubMed
2019-08-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berman JDJ D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimonyMajor topic
Antiprotozoal AgentsMajor topic
LeishmaniaMajor topic
LeishmaniasisMajor topic
Leishmaniasis, VisceralMajor topic
Animals
Chemical Phenomena
Chemistry
Energy Metabolism
Humans
Lipid Metabolism
Polyamines
Purines

Source PubMed

Download CSV of topics

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 329 citations.

PMIDTitleJournalYearIn PapersSource
41835577Nucleoside Analogue with Thymidine Nucleobase Inhibits Leishmania infantum and Depolarizes the Plasma Membrane Potential In Vitro.ACS Omega2026https://conductscience.org/library/papers/41835577PubMed
41023664Long-term trends of visceral leishmaniasis incidence and mortality in India 1990-2019: an application of joinpoint and age-period-cohort analysis.BMC Infect Dis2025https://conductscience.org/library/papers/41023664PubMed
39981004Design, synthesis and biological activity of peptidyl β-nitrostyrenes as cysteine protease inhibitors against Leishmania donovani.RSC Adv2025https://conductscience.org/library/papers/39981004PubMed
39752369Progress in antileishmanial drugs: Mechanisms, challenges, and prospects.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/39752369PubMed
38716320The Effectiveness of Perovskia abrotanoides Extract Topical Formulation on the Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial.J Res Pharm Pract2023https://conductscience.org/library/papers/38716320PubMed
36964053Small-molecule correctors and stabilizers to target p53.Trends Pharmacol Sci2023https://conductscience.org/library/papers/36964053PubMed
36422934Assessment of Immune and Clinical Response in Patients with Mucosal Leishmaniasis Treated with Pentavalent Antimony and Pentoxifylline.Trop Med Infect Dis2022https://conductscience.org/library/papers/36422934PubMed
36211958
Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area.
Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36211958PubMed
35457536Availability, Toxicology and Medical Significance of Antimony.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35457536PubMed
34245362Potential of Piper spp. as a source of new compounds for the leishmaniases treatment.Parasitol Res2021https://conductscience.org/library/papers/34245362PubMed
32325815In Vitro Anti-Leishmanial Effect of Metallic Meso-Substituted Porphyrin Derivatives against Leishmania braziliensis and Leishmania panamensis Promastigotes Properties.Molecules2020https://conductscience.org/library/papers/32325815PubMed
31430693The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.Int J Parasitol Drugs Drug Resist2019https://conductscience.org/library/papers/31430693PubMed
28615844The antileishmanial effects of Lowsonia inermis and Cedrus libani on Leishmania major promastigotes: an in vitro study.J Parasit Dis2017https://conductscience.org/library/papers/28615844PubMed
28242356Glycyrrhizic acid attenuates growth of Leishmania donovani by depleting ergosterol levels.Exp Parasitol2017https://conductscience.org/library/papers/28242356PubMed
24824136
Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.
Molecules2014https://conductscience.org/library/papers/24824136PubMed
23263387Molecular, cytological, and immunocytochemical study and kDNA sequencing of laryngeal Leishmania infantum infection.Parasitol Res2013https://conductscience.org/library/papers/23263387PubMed
22201704Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.Oncotarget2011https://conductscience.org/library/papers/22201704PubMed
22114501Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light.Int J Nanomedicine2011https://conductscience.org/library/papers/22114501PubMed
22091408Use of antimony in the treatment of leishmaniasis: current status and future directions.Mol Biol Int2011https://conductscience.org/library/papers/22091408PubMed
21716553Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate.Indian J Dermatol2011https://conductscience.org/library/papers/21716553PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3293160

GET https://conductscience.org/api/papers/v1/3293160/cited_by?page=2